Clopidogrel
Showing 26 - 50 of 1,574
Bioequivalence Trial in Karachi (Clopid® 75 mg Tablet, Plavix® 75mg Tablet)
Completed
- Bioequivalence
- Clopid® 75 mg Tablet
- Plavix® 75mg Tablet
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and Clinical Research (CBSCR)
Feb 14, 2022
Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,
Not yet recruiting
- Ischemic Stroke
- Vertebral Artery Stenosis
- Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
- +2 more
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 1, 2023
Scleroderma, Systemic Sclerosis Trial in France (clopidogrel treatment, Placebo)
Recruiting
- Scleroderma
- Systemic Sclerosis
- clopidogrel treatment
- Placebo
-
Bordeaux, France
- +8 more
Oct 17, 2022
Platelet Reactivity Trial in Harbin (Ticagrelor 90mg, Clopidogrel 75mg)
Completed
- Platelet Reactivity
- Ticagrelor 90mg
- Clopidogrel 75mg
-
Harbin, Heilongjiang, ChinaThrombelastogram
Dec 20, 2021
Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)
Not yet recruiting
- Acute Ischemic Stroke
- Thrombocytopenia
- aspirin, clopidogrel, cilostazol, and dipyridamole
- (no location specified)
Sep 21, 2023
End-Stage Renal Disease, Kidney Failure, Chronic Trial in Tampa, Jerusalem, Bucure?ti (MK-2060)
Active, not recruiting
- End-Stage Renal Disease
- Kidney Failure, Chronic
-
Tampa, Florida
- +2 more
Oct 26, 2022
Multi Vessel Coronary Artery Disease Trial in Seoul (Ticagrelor, Clopidogrel)
Not yet recruiting
- Multi Vessel Coronary Artery Disease
- Ticagrelor
- Clopidogrel
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Dec 20, 2021
Silent Brain Infarction Trial in Oklahoma City (Clopidogrel treatment, Aspirin treatment)
Recruiting
- Silent Brain Infarction
- Clopidogrel treatment
- Aspirin treatment
-
Oklahoma City, OklahomaOklahoma City VA Medical Center, Oklahoma City, OK
Apr 1, 2022
Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +
Recruiting
- Myocardial Infarction
- +2 more
- P2Y12 Potent Inhibitor + Aspirin for STEMI patients
- Clopidogrel + Aspirin for CCS patients
-
Messina, ItalyAOU Policlinico G. Martino
Jan 21, 2023
De Novo Stenosis, Coronary Artery Disease Trial in Xi'an (Swide Paclitaxel coated balloon, Firebird2 Sirolimus eluting stents,
Active, not recruiting
- De Novo Stenosis
- Coronary Artery Disease
- Swide Paclitaxel coated balloon
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban
Not yet recruiting
- Patient With Anterior Myocardial Infarction
- -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
- (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
-
Sohag, EgyptSohag University Hospital
Feb 16, 2023
Myocardial Infarction, Thrombosis, Platelet Dysfunction Trial in Lancaster (Clopidogrel, Ticagrelor)
Recruiting
- Myocardial Infarction
- +2 more
- Clopidogrel
- Ticagrelor
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 24, 2022
Platelet Reactivity Trial in Harbin (low-dose ticagrelor, Clopidogrel)
Completed
- Platelet Reactivity
- low-dose ticagrelor
- Clopidogrel
-
Harbin, California, ChinaVerifyNow
Dec 20, 2021
Thromboembolic Complications Associated With Coil Embolization
Completed
- Thromboembolic Stroke
- +4 more
- Aspir-Low Pill
-
Lahore, Punjab, PakistanUmair Rasheed
Aug 21, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +
Not yet recruiting
- Coronary Artery Disease
- +2 more
- Aspirin + Clopidogrel + Rivaroxaban
- Aspirin + Clopidogrel
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022
Coronary Artery Disease Trial in Nanjing (Ticagrelor, Clopidogrel)
Withdrawn
- Coronary Artery Disease
- Ticagrelor
- Clopidogrel
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Aug 18, 2021
Ischemic Stroke, Atrial Fibrillation Trial (Left atrial appendage Occlusion and 3 months of Clopidogrel, DOAC)
Not yet recruiting
- Ischemic Stroke
- Atrial Fibrillation
- Left atrial appendage Occlusion and 3 months of Clopidogrel
- DOAC
- (no location specified)
Jul 27, 2023
Coronary Artery Disease Trial in Seoul (Aspirin, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Aspirin
- Clopidogrel
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 8, 2022
Coronary Artery Disease, Peripheral Vascular Disease, Myocardial Infarction Trial in Falls Church (Vorapaxar, Vorapaxar and
Completed
- Coronary Artery Disease
- +2 more
- Vorapaxar
- +3 more
-
Falls Church, VirginiaInova Fairfax Hospital
Jul 22, 2022
Atherosclerotic Cardiovascular Disease Trial in Jacksonville (Evolocumab, Placebo)
Completed
- Atherosclerotic Cardiovascular Disease
- Evolocumab
- Placebo
-
Jacksonville, FloridaUniversity of Florida
Feb 16, 2022
Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)
Enrolling by invitation
- Heart Diseases
- +9 more
- Clopidogrel
- Aspirin
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 24, 2022
Clopidogrel Trial in Monastir (Platelet function assay)
Active, not recruiting
- Clopidogrel
- Platelet function assay
-
Monastir, TunisiaFattouma Bourguiba Hospital
Sep 12, 2021
Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)
Recruiting
- Drug Resistance
- additional blood sample
-
Paris, France
- +3 more
Nov 12, 2021
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022